EVH Stock Recent News

Evolent Health is a high growth stock that has rewarded shareholders with tremendous upside. The company has been reinvesting heavily into its growth initiatives at high rates of return.

WASHINGTON , Jan. 31, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its fourth quarter 2022 financial results on Wednesday, February 22, 2023 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

WASHINGTON , Nov. 29, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley, Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences. A live audio-only webcast and replay for these events will be available on the Investor Relations section of Evolent's website at http://ir.evolenthealth.com/, unless otherwise noted below.

Evolent Health announced its next deal, intensifying its relationship with Centene in the meantime. The deal is a bit complicated but has potential, as underlying sales growth has been accelerating.

For the second time in nearly as many days, the company's shares got a price target haircut.

Evolent Health (EVH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Call Start: 18:03 Evolent Health, Inc. (NYSE:EVH ) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Charles Rhyee - Cowen & Co. Sean Dodge - RBC Capital Markets Ryan Daniels - William Blair Sandy Draper - Guggenheim David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Operator Welcome to Evolent Health's Earnings Conference Call for the Third Quarter Ended September 30, 2022. As a reminder, this conference call is being recorded.

Here is how Evolent Health (EVH) and KVH Industries (KVHI) have performed compared to their sector so far this year.

WASHINGTON , Oct. 13, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its third quarter 2022 operating results on Wednesday, November 2, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

WASHINGTON , Sept. 9, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and related solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences.